All Type of News
Daewoong Pharmaceutical acquires Canadian GMP approval for Nabota factory
The Daewoong Pharmaceutical’s(CEO Seung-Ho Jeon) Nabora factory acquired the cGMP approval from the U.S. FDA on the last 15th, and acquired the GMP approval from the Health Canada on the 18th.
Daewoong Pharmaceutical...
Female officers at listed pharmas show outstanding activities in management, R&D and marketing
The women officer ratio at listed pharmaceutical companies is only 8%, but they are evaluated to distinguish themselves with outstanding activities in various fields, such as sales, marketing and R&D.
Yakup Shinmoon(...
How listed pharmaceutical companies spent on SG&A expenses in 1st quarter?
In the 1st quarter of this year, KOSDAQ listed pharmaceutical companies had a significantly higher average SG&A(selling, general and administrative) expense increase rate compared to the same quarter of the last year ...
‘Big 5’ pharmaceutical companies struggling with overseas sales/exports
The ‘Big 5’ pharmaceutical companies had differing results in overseas sales & exports in this 1st quarter.
GC Pharm and Hanmi Pharm had an increase, but the rest failed to do so. When it comes to the ratio of overse...
Government, “No damage on medical field from Moon Jae-In Care”
The Ministry of Health and Welfare(MOHW) stressed health care service providers, such as pharmacies, dentists and Korean medicine doctors, would not take any tangible damage from the Moon Jae-In Care at this year’s he...
Obesity therapy Saxenda lands in 10 general hospitals including Seoul National University Hospital
Novo Nordisk Korea(CEO Rana Azfar Zafar) announced on the 21st that ‘Saxenda® (generic name: liraglutide 3.0mg),’ the world’s first and only GLP-1(Glucagon-Like Peptide 1) analogue for the treatment of obesity, will b...
Pfizer Pharmaceuticals Korea signs co-promotion of ‘Prevenar 13’ with CKD
Pfizer Pharmaceuticals Korea(CEO Dong-Wook Oh) and Chong Kun Dang(CEO Young-Joo Kim, CKD) singed a Korean co-promotion partnership agreement of ‘Prevenar®13’ adult products, a Pfizer Pharmaceuticals Korea’s pneumococc...
51 pharmas selected as ‘2018 Hidden Champions’
51 pharmaceutical companies, such as Yuyu Pharma, UNIMED and Medytox, were selected as the 2018 hidden champions. Distribution companies were selected more with 255 companies.
Yakup Shinmoon(www.yakup.com) analyzed t...
How ‘Big 5’ pharmas did with R&D expenses in 1st quarter?
The ‘Big 5’ pharmaceutical companies’ amount spent on R&D in this 1st quarter was narrowly increased year-on-year. The percentage of the amount to sales passed 12% on average. While Green Cross, Hanmi Pharm and Daewoo...
Listed pharmas with women officer ratio less than 8%
It is even less than 1 of 10 officers in Korean listed pharmaceutical companies were reportedly women, which criticizes that the Korean pharmaceutical industry is an field with thick glass ceiling.
Yakup Shinmoon(www...
